First-in-man experience with a new 7F vascular closure device (EXOSEAL™): the 7F ECLIPSE study.

@article{Wiemer2012FirstinmanEW,
  title={First-in-man experience with a new 7F vascular closure device (EXOSEAL™): the 7F ECLIPSE study.},
  author={Marcus Wiemer and Christoph Langer and Stephan Fichtlscherer and Christian Firschke and Florian Hofbauer and Markus Lins and Michael Haude and Christof Deb{\`e}fve and H. J. Stoll and Christoph Hanefeld},
  journal={Journal of interventional cardiology},
  year={2012},
  volume={25 5},
  pages={518-25}
}
OBJECTIVE This feasibility study examined safety and effectiveness of the new EXOSEAL™ Vascular Closure Device (VCD) designed to promote hemostasis and early ambulation after percutaneous procedures. BACKGROUND Most VCDs currently approved by the United States FDA have been associated with significantly shorter time-to-hemostasis (TTH) and time-to-ambulation (TTA) compared to standard manual or mechanical compression, but their ease of use, patient comfort during deployment, and safety… CONTINUE READING